Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 167.90
-0.14 (-0.08%)
Apr 2, 2026, 3:30 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 76.15 billion as of April 2, 2026. Its market cap has decreased by -15.29% in one year.
Market Cap
76.15B
Enterprise Value
73.05B
Revenue
28.03B
Ranking
n/a
PE Ratio
21.14
Stock Price
167.90
Market Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 76.15B, an increase of 1,985.40%. That is a compound annual growth rate of 17.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 76.15B | -6.79% |
| Dec 31, 2025 | 81.70B | -39.22% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.57T |
| Apollo Hospitals Enterprise | 1.05T |
| Cipla | 966.03B |
| Strides Pharma Science | 88.82B |
| Metropolis Healthcare | 87.96B |
| Jupiter Life Line Hospitals | 81.75B |
| HealthCare Global Enterprises | 79.90B |